3-amino-2-cyanoquinoxaline-1,4-diium-1,4-bis(olate) - CAS 23190-84-3
Catalog: |
BB017974 |
Product Name: |
3-amino-2-cyanoquinoxaline-1,4-diium-1,4-bis(olate) |
CAS: |
23190-84-3 |
Synonyms: |
3-amino-1,4-dioxido-2-quinoxaline-1,4-diiumcarbonitrile; 3-amino-1,4-dioxidoquinoxaline-1,4-diium-2-carbonitrile |
IUPAC Name: | 3-amino-1,4-dioxidoquinoxaline-1,4-diium-2-carbonitrile |
Description: | 3-amino-2-cyanoquinoxaline-1,4-diium-1,4-bis(olate) (CAS# 23190-84-3) is a useful research chemical. |
Molecular Weight: | 202.173 |
Molecular Formula: | C9H6N4O2 |
Canonical SMILES: | C1=CC=C2C(=C1)[N+](=C(C(=[N+]2[O-])N)C#N)[O-] |
InChI: | InChI=1S/C9H6N4O2/c10-5-8-9(11)13(15)7-4-2-1-3-6(7)12(8)14/h1-4H,11H2 |
InChI Key: | ZGVCESZATUMTIM-UHFFFAOYSA-N |
Boiling Point: | 571.516 °C at 760 mmHg |
Density: | 1.553 g/cm3 |
MDL: | MFCD00102307 |
LogP: | 1.73188 |
Publication Number | Title | Priority Date |
CN-105601575-A | Quinoxaline-N1,N4-dioxide derivatives with antimicrobial activity | 20160129 |
EP-3138565-A1 | Method for treating a tumour disease and method for selectively inhibiting tumour cell growth using a quinoxaline-1,4-dioxide derivative | 20140428 |
WO-2015167350-A1 | Method for treating a tumour disease and method for selectively inhibiting tumour cell growth using a quinoxaline-1,4-dioxide derivative | 20140428 |
AU-2009222040-A1 | Amino-quinoxaline and amino-quinoline compounds for use as adenosine A2a receptor antagonists | 20080304 |
CA-2717171-A1 | Amino-quinoxaline and amino-quinoline compounds for use as adenosine a2a receptor antagonists | 20080304 |
PMID | Publication Date | Title | Journal |
20701975 | 20101101 | Design of novel iron compounds as potential therapeutic agents against tuberculosis | Journal of inorganic biochemistry |
20236735 | 20100701 | New quinoxaline 1, 4-di-N-oxides: anticancer and hypoxia-selective therapeutic agents | European journal of medicinal chemistry |
19162490 | 20090215 | Cytotoxic palladium complexes of bioreductive quinoxaline N1,N4-dioxide prodrugs | Bioorganic & medicinal chemistry |
17804074 | 20080101 | New copper-based complexes with quinoxaline N1,N4-dioxide derivatives, potential antitumoral agents | Journal of inorganic biochemistry |
16709457 | 20060815 | Improving anti-trypanosomal activity of 3-aminoquinoxaline-2-carbonitrile N1,N4-dioxide derivatives by complexation with vanadium | Bioorganic & medicinal chemistry |
Complexity: | 289 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 202.04907545 |
Formal Charge: | 0 |
Heavy Atom Count: | 15 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 202.04907545 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 101 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -0.5 |
-
Catalog: BB044025
1-Dimethoxymethyl-2-methylbenzene
Detail
-
Catalog: BB054390
Methyl 2-(bromomethyl)-3-fluorobenzoate
Detail
-
Catalog: BB008128
1-chloro-7-(trifluoromethyl)phthalazine
Detail
-
Catalog: BB044016
11-chloro-7-fluoro-2-isopropyl-10,11-dihydrodibenzo[b,f]thiepin
Detail
-
Catalog: BB007529
11-bromo-1,8,10-triazatricyclo[7.4.0.0²,⁷]trideca-2(7),3,5,8,10,12-hexaene
Detail
-
Catalog: BB054380
Benzo[ghi]perylene
Detail
-
Catalog: BB008250
4-(methylamino)-1,2-dihydrophthalazin-1-one
Detail
-
Catalog: BB000315
(2,2-Dimethyl-1-propyl)benzene
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Arenes
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS